Life sciences news

Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients

Wednesday December 20th 2023

Read more
argenx reports topline results from ADDRESS study of efgartigimod SC in pemphigus

Wednesday December 20th 2023

Read more
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301

Wednesday December 20th 2023

Read more
Biotalys announces results of independent field trials in the U.S.

Tuesday December 19th 2023

Read more
Mithra receives positive DSMB Opinion on DONESTA® European Phase 3 Trial

Monday December 18th 2023

Read more
Belgian researchers find a crack in the wall of WHO’s top priority pathogens

Thursday December 14th 2023

Read more
AstriVax awarded €3 million grant to advance therapeutic Hepatitis B vaccine

Tuesday December 12th 2023

Read more
Almirall and etherna enter into a multi-target alliance to develop mRNA-based therapies in medical dermatology

Tuesday December 12th 2023

Read more
Your news here?

Become a flanders.bio member
KU Leuven formally opens new research centre for innovative gene therapy

Friday December 8th 2023

Read more
VUB team develops nanobody technology against liver inflammation

Monday December 4th 2023

Read more
Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China

Monday December 4th 2023

Read more

More info?

Communication Coordinator